Newsbenzinga
BridgeBio Pharma Receives FDA Acceptance For Filing Its New Drug Application With Priority Review For Oral Infigratinib To Treat Achondroplasia
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…